International Society of Addiction Medicine Annual Conference

摘要 国际成瘾医学会(ISAM)致力于提供支持性学术支持 向国际成瘾医学领域的成员提供网络。我们通过电子设备来实现这一点 交流，就与该领域有关的问题制定协商一致的立场文件，所有研究 与药物成瘾和相关的共同发病有关的领域，包括艾滋病毒等感染，以及每年 举行会议，传播世界各地同事在这一领域取得的进展，重点是 为资源相对较少的国家的从业者提供机会 参与/出席。我们还建立了成瘾问题国际认证程序。 医学。因此，ISAM自1999年以来一直致力于促进世界各地的更好了解，其中包括 成瘾医学领域的医生和相关保健专业人员，以及药物之间的联系 虐待，心理/精神后果，以及包括艾滋病毒和其他血液在内的疾病过程- 传播的病原体。这一合作的一个重要成果是认识到 物质滥用的“全球”因素，与医疗/精神/社会后果相关，无论 种族、性别、文化或民族。我们在一个援助的国家组织/举办会议 来自世界各地的临床医生将帮助当地的临床成瘾医学专家 加强必要的成瘾/临床医学服务。我们的目标是，建设一个强大、团结、知情的 与其他学科合作发出医学声音，代表患者在预防和 全球成瘾管理，得到了我们的年度会议的大力支持 NIH/NIDA会议补助金提供的财政和咨询援助(2006年；2007-2010年；2011-2015年)。 正在通过这项续签申请寻求资金，以支持2016-2020年举行的年度会议 在不同的国家。目前，2014年日本横滨会议刚刚闭幕。场馆 因为随后的年度会议将在联合王国苏格兰邓迪(2015)、里约热内卢 巴西里约热内卢(2016)、阿联酋阿布扎比(2017)和韩国釜山(2018)。(2019-20场馆将是 决定了，但暂定将于2019年在土耳其伊兹密尔，或者在北京，中国或班加罗尔， 印度2020)。 虽然本组织和我们的会议在NIDA的帮助下有了很大的发展，但我们计划 保留未来会议的独特元素，这些元素将有助于设定“人物”。其中包括：1) 综合学术/娱乐服务，2)正式的公开讨论/交流机会 总结计划会议，3)包括会议计划内容，以介绍新的/新兴的 成瘾和相关发病率的科学，包括艾滋病毒、丙型肝炎病毒和其他感染，4) 系统地改变全球会议的地理位置，促进当地出席/区域会议 进入，以及5)致力于支持/指导青年/经济以下儿童的大学发展- 全球成瘾医学界的资源丰富的成员。该组织受益于 不仅来自上届会议提供的财政和协商支助 格兰特，但由于NIDA执行人员的大量专业知识、时间和思想 他们接受了邀请，在过去的会议上发言，这是我们的荣幸。我们期待着继续 这种联系为我们的议事程序提供了最有意义的补充，也是重要的 激励该组织希望为其服务的年轻科学家/成瘾药物从业者 提供一种相互指导和合作的氛围。因此，继续这样的支持是非常高的 将ISAM作为一个组织的优先事项。 首席调查员联系人： 格雷戈里·C·班特博士 高级副总裁/医疗 天顶村，Inc. 西40街54号，5楼 纽约州纽约市，邮编10018 电话：(212)354-6000，分机220 传真：(212)391-9265 电子邮件：gbunt@day top.org ISAM总部联系人 纳迪·盖巴利博士 ISAM首席审查员 FMC成瘾中心 西北大街1403-29号 卡尔加里AB T2N 2T9 电话：(403)944-2025 传真：(403)944-2056 电子邮件：nady.el-guebaly@calgaryHealth Region.ca

Abstract The International Society of Addiction Medicine (ISAM) is dedicated to providing a supportive academic network to members of the international addiction medicine field. We accomplish this via electronic communication, development of consensual position papers on issues relevant to the field, research in all areas relating to drug addiction and associated co-morbidity including infections such as HIV, and annual conferences to disseminate information on advances in the field by colleagues worldwide, with a priority on providing opportunities for practitioners from countries with relatively few resources to participate/present. We have also established a process of International Certification in Addiction Medicine. ISAM has thus been working since 1999 to promote better understanding worldwide, among physicians and allied health professionals in the field of addiction medicine, of connections among drug abuse, psychological/psychiatric consequences, and disease processes including HIV and other blood- borne pathogens. One significant outcome of this collaboration has been the recognition that there are “global” factors in substance abuse, associated with medical/psychiatric/social consequences regardless of race, gender, culture, or ethnicity. We organize/present conferences in a country where the assistance from clinicians from around the world would help the local clinical addiction medicine experts in setting up the necessary addiction/clinical medicine services. Our goal, to build a strong, united, informed medical voice in collaboration with other disciplines to speak on behalf of patients in prevention and management of addictions worldwide, has been significantly supported by our annual conferences with fiscal and advisory assistance provided by NIH/NIDA Conference Grants (2006; 2007-2010; 2011-2015). Funds are being sought through this renewal application to support annual meetings 2016-2020 to be held in different countries. Currently the Yokohama, Japan, 2014 conference has just concluded. The venues for the subsequent Annual Conferences will be in Dundee, Scotland, United Kingdom (2015), Rio de Janeiro, Brazil (2016), Abu Dhabi, UAE (2017) and Busan, Korea (2018). (2019-20 venues are to be determined, but tentatively will be in Izmir, Turkey, 2019, and either in Beijing, China or in Bangalore, India 2020). While the organization and our conference have evolved significantly with NIDA’s assistance, we plan to retain unique elements of the future conferences that will help set “characters.” Those include: 1) integrated academic/recreational offerings, 2) formalized opportunities for open discussion/exchange concluding program sessions, 3) inclusion of conference program content to present new/emerging science of addiction and associated morbidity including infections such as HIV, HCV and others,4) systematically varying global geographic sites of conferences, promoting local attendance/regional access, and 5) dedication to support/mentorship for collegial development of young/economically under- resourced members of the worldwide addiction medicine community. The organization has benefited significantly from not only the financial and consultative support afforded by the previous conference grant, but by the significant expertise, time, and thought of many members of the NIDA executive staff who have honored us by accepting invitations to speak at past meetings. We look forward to continuing that association, which has provided most meaningful additions to our proceedings as well as important inspiration to younger scientists/addiction medicine practitioners for whom the organization desires to provide an atmosphere of mentorship and collegiality. Thus continuing such support is of very high priority to ISAM as an organization. Principal Investigator Contact: Dr. Gregory C. Bunt Senior Vice-President/Medical Daytop Village, Inc. 54 West 40th St., 5th Floor New York, N.Y. 10018 Tel: (212) 354-6000, ext. 220 Fax: (212) 391-9265 Email: gbunt@daytop.org ISAM Head Office Contact Dr. Nady el-Guebaly Chief Examiner, ISAM FMC Addiction Centre 1403 – 29 Street NW Calgary AB T2N 2T9 Tel: (403) 944-2025 Fax: (403) 944-2056 Email: nady.el-guebaly@calgaryhealthregion.ca